Clinical Trials Directory

Trials / Completed

CompletedNCT01181492

Impact of CYP3A4*1G Polymorphism on Metabolism of Fentanyl in Chinese Patients Undergoing Lower Abdominal Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
176 (actual)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Purpose: This study aimed to investigate the impact of CYP3A4\*1G genetic polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery. Methods: 176 patients receiving elective lower abdominal surgery under general anesthesia were recruited into this study. Genotyping of CYP3A4\*1G was carried out by direct sequencing. The plasma fentanyl concentration was detected 30 min after anesthesia induction by high performance liquid chromatography-ultraviolet ray (HPLC-UV). The visual analog scale (VAS) was used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 0 h, 12 h and 24 h after operation. PCA fentanyl consumption and adverse effects were recorded during the first 24 h after surgery.

Conditions

Timeline

Start date
2008-11-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2010-08-13
Last updated
2013-11-01
Results posted
2013-11-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01181492. Inclusion in this directory is not an endorsement.